GS1-144 for women with liver problems and healthy women
This trial tests a drug called GS1-144 in women with mild to moderate liver problems and in healthy women. It aims to see how the drug works differently based on liver function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 70 years old.
- Your body weight is at least 45 kg (99 pounds) and your BMI is between 18 and 32.
- If you have liver problems, they must be mild or moderate (Child-Pugh class A or B).
- You must be willing to use effective birth control from signing the consent form until 1 month after taking the drug.
- If you are healthy, you must have normal lab results and no serious medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the body processes and tolerates a new experimental drug (MDR-001) in people with mild to moderate liver disease. The research helps doctors understand if the drug is safe and how it works when liver function is reduced.
This is an early-stage study testing a new medicine called PF-08653944 in healthy adults and in people with varying degrees of liver function problems. The goal is to understand how the medicine works in the body and how liver function affects how the body processes it.
This trial tests how a drug (BMS-986435) behaves in people with normal liver function versus those with liver problems. It also checks that the drug is safe for the heart.
This trial tests how the drug HS-10241 works in people with mild to moderate liver impairment compared to those with normal liver function. It aims to help doctors understand the right dose and safety in people with liver disease.
This study looks at how the medicine PF-07328948 is processed by people with different levels of liver function. It includes both healthy people and those with stable liver disease (classified as mild, moderate, or severe). The goal is to see if the liver condition affects how the drug works in the body.
This trial is testing a new medicine called GS3-007a (a dry powder you take mixed with liquid) to see if it's safe in healthy people. If you join, you'll help doctors understand how the body handles the drug and what side effects might occur.
Hear when a new Hepatic Impairment and Healthy Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.